Literature DB >> 18838890

Qualitative age-interactions in breast cancer: a tale of two diseases?

Ismail Jatoi1, William F Anderson, Philip S Rosenberg.   

Abstract

A qualitative age-interaction is defined as the reversal of relative risks or rates according to age at onset. Once thought rare, qualitative age-interactions are commonly reported in studies that examine the etiology, prognosis, and treatment of breast cancer. Thus, nulliparity, obesity, and oral contraceptives decrease breast cancer risk in younger women but increase risk in older women. High-risk tumors are more common in younger women, whereas low-risk tumors are more common among the elderly, with bimodal peak frequencies at ages 50 and 70, respectively. Curves depicting the annual hazard of breast cancer death for women with high-risk (early-onset) and low-risk (late-onset) tumors are shaped differently and move in opposite directions. Additionally, mammography screening and neo-adjuvant chemotherapy seem to have opposing effects in women with early and late-onset tumors. Taken together, these qualitative age-interactions may indicate that early and late-onset breast cancers are different diseases, derived from different pathways.

Entities:  

Mesh:

Year:  2008        PMID: 18838890     DOI: 10.1097/COC.0b013e3181844d1c

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  9 in total

Review 1.  Fat circadian biology.

Authors:  Jeffrey M Gimble; Z Elizabeth Floyd
Journal:  J Appl Physiol (1985)       Date:  2009-05-21

2.  Motor phenotypes and molecular networks associated with germline deficiency of Ciz1.

Authors:  Jianfeng Xiao; Satya R Vemula; Yi Xue; Mohammad M Khan; Korah P Kuruvilla; Esther M Marquez-Lona; Madison R Cobb; Mark S LeDoux
Journal:  Exp Neurol       Date:  2016-05-07       Impact factor: 5.330

3.  Young age, increased tumor proliferation and FOXM1 expression predict early metastatic relapse only for endocrine-dependent breast cancers.

Authors:  Christina Yau; Yixin Wang; Yi Zhang; John A Foekens; Christopher C Benz
Journal:  Breast Cancer Res Treat       Date:  2011-01-12       Impact factor: 4.872

4.  Time to Surgery and Breast Cancer Survival in the United States.

Authors:  Richard J Bleicher; Karen Ruth; Elin R Sigurdson; J Robert Beck; Eric Ross; Yu-Ning Wong; Sameer A Patel; Marcia Boraas; Eric I Chang; Neal S Topham; Brian L Egleston
Journal:  JAMA Oncol       Date:  2016-03       Impact factor: 31.777

5.  The effect of local therapy on breast cancer mortality: is there an age-interaction?

Authors:  Ismail Jatoi
Journal:  Indian J Surg Oncol       Date:  2013-11-05

6.  Procyanidin b2 cytotoxicity to mcf-7 human breast adenocarcinoma cells.

Authors:  Monalisa M Avelar; Cibele M C P Gouvêa
Journal:  Indian J Pharm Sci       Date:  2012-07       Impact factor: 0.975

7.  Ethnic and socioeconomic trends in breast cancer incidence in New Zealand.

Authors:  Ruth Cunningham; Caroline Shaw; Tony Blakely; June Atkinson; Diana Sarfati
Journal:  BMC Cancer       Date:  2010-12-07       Impact factor: 4.430

8.  Global breast cancer: the lessons to bring home.

Authors:  Silvia C Formenti; Alan A Arslan; Susan M Love
Journal:  Int J Breast Cancer       Date:  2011-12-05

9.  Genetically heterogeneous mice exhibit a female survival advantage that is age- and site-specific: Results from a large multi-site study.

Authors:  Catherine J Cheng; Jonathan A L Gelfond; Randy Strong; James F Nelson
Journal:  Aging Cell       Date:  2019-02-23       Impact factor: 9.304

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.